)
Jyong Biotech (MENS) investor relations material
Jyong Biotech AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic initiatives and plans
MCS-2 product offers a unique mechanism of action for benign prostatic hyperplasia, addressing unmet patient needs with a strong safety profile.
Positioned among the first five companies to receive FDA phase III clinical trial approval for a botanical drug, with potential for early market entry.
Key challenges and risks discussed
Emphasis on the lack of effective current treatments for benign prostatic hyperplasia highlights the market need and potential hurdles in patient care.
- Net losses persist, no revenue generated, and major regulatory and legal risks threaten viability.MENS
Q4 2025 - Biotech with no revenue seeks Nasdaq IPO to fund trials, facing high financial and legal risks.MENS
Registration Filing - Pre-revenue biotech targeting urinary diseases seeks Nasdaq IPO amid high financial and regulatory risk.MENS
Registration Filing - Pre-revenue biotech seeks Nasdaq IPO to fund clinical trials amid high regulatory and legal risks.MENS
Registration Filing - Biotech seeks Nasdaq IPO to fund clinical trials amid high financial and regulatory risk.MENS
Registration Filing - Pre-revenue biotech seeks Nasdaq IPO to fund clinical trials amid high regulatory and legal risks.MENS
Registration Filing - Pre-revenue biotech seeks Nasdaq IPO to fund clinical trials amid high financial and legal risks.MENS
Registration Filing - Biotech seeks Nasdaq IPO to fund clinical trials amid high regulatory and financial risk.MENS
Registration Filing - Biotech seeks $17.8M IPO to fund clinical trials amid high regulatory and legal risks.MENS
Registration Filing
Next Jyong Biotech earnings date
Next Jyong Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)